Acquisition Multiples: 1.9 times current revenue and roughly 15 times EBITDA. Tempus AI Inc (NASDAQ:TEM) reported a 33% revenue growth, reaching $180.9 million for Q3 2024. The company's data and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TEM aims to leverage AI and ML and revolutionize healthcare diagnostics, a space which has large gaps and is relatively untapped. Despite an impressive revenue profile and a burgeoning data ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Our observations underscore that leukocyte diapedesis is not a random event but occurs at predefined exit-sites. As TEM is a very rapid process (leukocytes cross the endothelium within 120 s), we used ...